Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$3.25 - $5.0 $0 - $0
0 New
0 $0
Q4 2023

Feb 07, 2024

BUY
$2.01 - $3.51 $0 - $0
0 New
0 $0
Q3 2023

Oct 30, 2023

BUY
$3.02 - $4.45 $0 - $0
0 New
0 $0
Q3 2023

Oct 25, 2023

BUY
$3.02 - $4.45 $0 - $0
0 New
0 $0
Q2 2023

Aug 10, 2023

BUY
$2.3 - $4.34 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023

BUY
$2.19 - $3.27 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023

BUY
$2.7 - $4.88 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022

BUY
$4.94 - $7.0 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022

BUY
$6.15 - $7.94 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022

SELL
$5.8 - $8.2 $4,071 - $5,756
-702 Closed
0 $0
Q4 2020

Feb 02, 2021

BUY
$6.7 - $12.2 $4,703 - $8,564
702 New
702 $5,000
Q3 2020

Nov 13, 2020

BUY
N/A
0 New
0 $0

Others Institutions Holding LNSR

About LENSAR, Inc.


  • Ticker LNSR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 11,021,000
  • Market Cap $49.6M
  • Description
  • LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...
More about LNSR
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.